Vericel Corporation (VCEL) — Analysis Summary
Vericel Corporation (VCEL) has a market cap of $1.70B with year-over-year revenue growth of +16.5%. Net margin stands at 6.0%. The stock trades at a P/E ratio of 79.3.
Key Takeaways
- Revenue changed +16.5% year-over-year
- Net margin of 6.0%
- P/E ratio of 79.3
Compared to other companies in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector, VCEL posted revenue growth of +16.5% and trades at a P/E of 79.3.
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.